المؤلفون: Sepe P, Mennitto A, Corti F, Procopio G

المصدر: ImmunoTargets and Therapy, Vol Volume 9, Pp 273-288 (2020)

مصطلحات موضوعية: metastatic renal cell carcinoma, immunotherapy, anti-pd-1, anti-ctla-4, targeted therapy, biomarkers, Immunologic diseases. Allergy, RC581-607

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/immunotherapeutic-targets-and-therapy-for-renal-cell-carcinoma-peer-reviewed-article-ITTTest; https://doaj.org/toc/2253-1556Test

الوصول الحر: https://doaj.org/article/6725adf7196b49c08966a1bc56a013bfTest

المؤلفون: Tommasi, Chiara, Scartabellati, Giulia, Giannarelli, Diana, Giorgi, Ugo De, Brighi, Nicole, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Buti, Sebastiano

المساهمون: Tommasi, Chiara, Scartabellati, Giulia, Giannarelli, Diana, Giorgi, Ugo De, Brighi, Nicole, Fornarini, Giuseppe, Rebuzzi, Sara Elena, Puglisi, Silvia, Caffo, Orazio, Kinspergher, Stefania, Mennitto, Alessia, Cattrini, Carlo, Santoni, Matteo, Verzoni, Elena, Rametta, Alessandro, Stellato, Marco, Malgeri, Andrea, Roviello, Giandomenico, Brunelli, Matteo, Buti, Sebastiano

مصطلحات موضوعية: anisocytosi, cabozantinib, macrocytosi, metastatic renal cell carcinoma, pazopanib, prognostic

وصف الملف: ELETTRONICO

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/37492625; info:eu-repo/semantics/altIdentifier/wos/WOS:001156531500001; volume:15; firstpage:1; lastpage:24; numberofpages:24; journal:THERAPEUTIC ADVANCES IN UROLOGY; https://hdl.handle.net/11562/1100728Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85165597211

الإتاحة: https://doi.org/10.1177/17562872231187216Test
https://hdl.handle.net/11562/1100728Test

المؤلفون: Alessia Mennitto, Veronica Huber, Raffaele Ratta, Pierangela Sepe, Filippo de Braud, Giuseppe Procopio, Valentina Guadalupi, Mélanie Claps, Marco Stellato, Elena Daveri, Licia Rivoltini, Elena Verzoni

المصدر: Journal of Clinical Medicine; Volume 9; Issue 4; Pages: 930

مصطلحات موضوعية: metastatic renal cell carcinoma, angiogenesis, immunotherapy, tyrosine-kinase inhibitors, immunomodulation, immune checkpoint inhibitors

وصف الملف: application/pdf

العلاقة: Immunology; https://dx.doi.org/10.3390/jcm9040930Test

الإتاحة: https://doi.org/10.3390/jcm9040930Test

المؤلفون: Grassi P, Verzoni E, Ratta R, Mennitto A, de Braud F, Procopio G

المصدر: Drug Design, Development and Therapy, Vol 2016, Iss Issue 1, Pp 2167-2172 (2016)

مصطلحات موضوعية: cabozantinib, XL-184, metastatic renal cell carcinoma, VEGF-inhibitor, C-Met, targeted therapy, Therapeutics. Pharmacology, RM1-950

وصف الملف: electronic resource

العلاقة: https://www.dovepress.com/cabozantinib-in-the-treatment-of-advanced-renal-cell-carcinoma-design--peer-reviewed-article-DDDTTest; https://doaj.org/toc/1177-8881Test

الوصول الحر: https://doaj.org/article/f3654a1f9952472cb2f83b6181daa5deTest

المؤلفون: Mennitto A, Zattarin E, Di Maio M, Bimbatti D, De Giorgi U, Buti S, Santini D, Casadei C, Sorarù M, Messina C, Mucciarini C, Di Lorenzo G, Roviello G, Buttigliero C, Stellato M, Sepe P, Claps M, Guadalupi V, Ottini A, Pignata S, De Braud FG, Verzoni E, Procopio G.

المساهمون: Mennitto A, Zattarin E, Di Maio M, Bimbatti D, De Giorgi U, Buti S, Santini D, Casadei C, Sorarù M, Messina C, Mucciarini C, Di Lorenzo G, Roviello G, Buttigliero C, Stellato M, Sepe P, Claps M, Guadalupi V, Ottini A, Pignata S, De Braud FG, Verzoni E, Procopio G.

مصطلحات موضوعية: Cabozantinib, kidney cancer treatment, metastatic renal cell carcinoma, post-progression survival, treatment beyond progression, Anilide, Female, Human, Male, Pyridine, Retrospective Studie, Carcinoma, Renal Cell, Kidney Neoplasms

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/34738499; volume:22; issue:1; firstpage:115; lastpage:121; numberofpages:7; journal:EXPERT REVIEW OF ANTICANCER THERAPY; https://hdl.handle.net/2318/1889180Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120347444

الإتاحة: https://doi.org/10.1080/14737140.2022.2002688Test
https://hdl.handle.net/2318/1889180Test

المؤلفون: P. Grassi, R. Ratta, G. Procopio, E. Verzoni, A. Mennitto, F. de Braud

المساهمون: P. Grassi, E. Verzoni, R. Ratta, A. Mennitto, F. de Braud, G. Procopio

مصطلحات موضوعية: c-Met, Ccbozantinib, metastatic renal cell carcinoma, targeted therapy, VEGF-inhibitor, XL-184, pharmacology, drug discovery3003, pharmaceutical science, Settore MED/06 - Oncologia Medica

الوقت: 3003

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27462141; info:eu-repo/semantics/altIdentifier/wos/WOS:000379332100001; volume:10; firstpage:2167; lastpage:2172; numberofpages:6; journal:DRUG DESIGN, DEVELOPMENT AND THERAPY; http://hdl.handle.net/2434/442270Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84978970987

الإتاحة: https://doi.org/10.2147/DDDT.S104225Test
http://hdl.handle.net/2434/442270Test

المؤلفون: Giuseppe Procopio, Filippo de Braud, Pierangela Sepe, Emma Zattarin, Giandomenico Roviello, Giuseppe Di Lorenzo, Arianna Ottini, Sebastiano Buti, Ugo De Giorgi, Sandro Pignata, Carlo Messina, Davide Bimbatti, Marco Stellato, Melanie Claps, Valentina Guadalupi, Daniele Santini, Consuelo Buttigliero, Massimo Di Maio, Elena Verzoni, Mariella Sorarù, Alessia Mennitto, Claudia Mucciarini, Chiara Casadei

مصطلحات موضوعية: Male, Oncology, medicine.medical_specialty, Cabozantinib, kidney cancer treatment, metastatic renal cell carcinoma, post-progression survival, treatment beyond progression, Pyridines, chemistry.chemical_compound, Renal cell carcinoma, Internal medicine, Clinical endpoint, Humans, Medicine, Anilides, Pharmacology (medical), Carcinoma, Renal Cell, Retrospective Studies, Prior treatment, Response rate (survey), business.industry, Carcinoma, Disease progression, Renal Cell, medicine.disease, Kidney Neoplasms, chemistry, Tolerability, Multicenter study, Female, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::df085081751c44b402fddadd370bc149Test
http://hdl.handle.net/11573/1642327Test

المؤلفون: Mennitto, A, Verzoni, E, Cognetti, F, Miceli, R, Milella, M, Mosca, A, Chiuri, V E, Bearz, A, Morelli, F, Ortega, C, Atzori, F, Donini, M, Claps, M, Guadalupi, V, Sepe, P, Cappelletti, V, de Braud, F G, Procopio, G

المساهمون: Mennitto, A, Verzoni, E, Cognetti, F, Miceli, R, Milella, M, Mosca, A, Chiuri, V E, Bearz, A, Morelli, F, Ortega, C, Atzori, F, Donini, M, Claps, M, Guadalupi, V, Sepe, P, Cappelletti, V, de Braud, F G, Procopio, G

مصطلحات موضوعية: Metastatic renal cell carcinoma, adjuvant treatment, relapse-free survival, sorafenib, surgical metastasectomy, targeted therapy, Antineoplastic Agents, Carcinoma, Renal Cell, Disease-Free Survival, Follow-Up Studies, Humans, Kidney Neoplasms, Metastasectomy, Neoplasm Recurrence, Local, Probability

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/33472450; info:eu-repo/semantics/altIdentifier/wos/WOS:000613363500001; volume:14; issue:2; firstpage:261; lastpage:268; numberofpages:8; journal:EXPERT REVIEW OF CLINICAL PHARMACOLOGY; http://hdl.handle.net/11562/1063756Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85100181589

الإتاحة: https://doi.org/10.1080/17512433.2021.1879639Test
http://hdl.handle.net/11562/1063756Test

المؤلفون: Mennitto A., Zattarin E., Di Maio M., Bimbatti D., De Giorgi U., Buti S., Santini D., Casadei C., Soraru M., Messina C., Mucciarini C., Di Lorenzo G., Roviello G., Buttigliero C., Stellato M., Sepe P., Claps M., Guadalupi V., Ottini A., Pignata S., De Braud F. G., Verzoni E., Procopio G.

المساهمون: Mennitto, A., Zattarin, E., Di Maio, M., Bimbatti, D., De Giorgi, U., Buti, S., Santini, D., Casadei, C., Soraru, M., Messina, C., Mucciarini, C., Di Lorenzo, G., Roviello, G., Buttigliero, C., Stellato, M., Sepe, P., Claps, M., Guadalupi, V., Ottini, A., Pignata, S., De Braud, F. G., Verzoni, E., Procopio, G.

مصطلحات موضوعية: Cabozantinib, kidney cancer treatment, metastatic renal cell carcinoma, post-progression survival, treatment beyond progression

العلاقة: info:eu-repo/semantics/altIdentifier/wos/WOS:000724011100001; firstpage:1-7; lastpage:7; journal:EXPERT REVIEW OF ANTICANCER THERAPY; http://hdl.handle.net/11381/2913798Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85120347444

الإتاحة: https://doi.org/10.1080/14737140.2022.2002688Test
http://hdl.handle.net/11381/2913798Test

المؤلفون: Franco Morelli, Francesco Atzori, Melanie Claps, Maddalena Donini, Alessandra Mosca, Vera Cappelletti, Alessandra Bearz, Rosalba Miceli, Elena Verzoni, Cinzia Ortega, Francesco Cognetti, M. Milella, Valentina Guadalupi, Pierangela Sepe, V.E. Chiuri, Alessia Mennitto, F. de Braud, Giuseppe Procopio

مصطلحات موضوعية: Sorafenib, Oncology, medicine.medical_specialty, relapse-free survival, medicine.medical_treatment, Cell, Metastatic renal cell carcinoma, adjuvant treatment, Antineoplastic Agents, urologic and male genital diseases, 030226 pharmacology & pharmacy, Relapse free survival, Disease-Free Survival, Targeted therapy, 03 medical and health sciences, 0302 clinical medicine, Renal cell carcinoma, Internal medicine, surgical metastasectomy, Medicine, Humans, Pharmacology (medical), In patient, General Pharmacology, Toxicology and Pharmaceutics, Carcinoma, Renal Cell, Probability, business.industry, Carcinoma, Metastasectomy, Renal Cell, General Medicine, medicine.disease, targeted therapy, Kidney Neoplasms, medicine.anatomical_structure, Neoplasm Recurrence, Local, 030220 oncology & carcinogenesis, Neoplasm Recurrence, Local, business, medicine.drug, Follow-Up Studies

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c32b2f4c30474e2235fb342aa61cd1a5Test
http://hdl.handle.net/11562/1063756Test